Alpenglow Biosciences® Email Format
Biotechnology ResearchWashington, United States11-50 Employees
Alpenglow Biosciences, based in Seattle, Washington, is a small to mid-sized biotechnology research company focused on accelerating drug development and clinical diagnostics through light-sheet 3D tissue imaging and AI-assisted analysis for spatial biology and digital pathology. Its Aurora 3D spatial biology platform digitizes intact tissue samples to produce quantitative 3D datasets while preserving tissue for downstream molecular analysis. Several of the world's top pharmaceutical companies collaborate with Alpenglow to discover biology in intact tissue, generate analysis-ready volumetric datasets and spatial metrics, and support AI model development with ground-truth 3D data. The company aims to improve decision-making in preclinical and clinical programs through these capabilities. In early 2026, Alpenglow announced a partnership with PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers.